Lipum Q2 report: One step back, one step forward - Redeye

Redeye provides a research update on Lipum following the Q2 report published by the company earlier today. We make some adjustments to our estimates following a higher cash burn than expected and the outcome of the recent rights issue. Accordingly, we slightly lower our fair value range (SEK4 – SEK32) with a revised base case valuation of SEK20 (22) as we continue to see significant upside potential in the stock.

Länk till analysen i sin helhet: https://www.redeye.se/research/927891/lipum-q2-report-one-step-back-one-step-forward?utm_source=finwire&utm_medium=RSS